Concepedia
1
Publications
713
Citations
H-Index
2007
Active since
Affiliations
Dana-Farber Cancer Institute(Current)
Christopher-Michael Gale is an author at Dana-Farber Cancer Institute.
Publications per year
2007–2007
PF00299804, an Irreversible Pan-ERBB Inhibitor, Is Effective in Lung Cancer Models with <i>EGFR</i> and <i>ERBB2</i> Mutations that Are Resistant to Gefitinib
Jeffrey A. Engelman, Kreshnik Zejnullahu, Christopher-Michael Gale et al. · Cancer Research · 2007 · 713 citations · Full text
Rows per page
1–1 of 1